ArticleActa pharmaceutica Sinica. B2026
Lactate metabolism and epigenetic reprogramming drive c-KIT hyperactivation to mediate Gilteritinib resistance: Rationale for c-KIT degraders over kinase inhibitors.
Yanli Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.